From: Trends in respiratory diseases before and after the COVID-19 pandemic in China from 2010 to 2021
Disease | Phase 1 reported cases | Phase 2/Model 1 | Phase 2/Model 2 | ||
---|---|---|---|---|---|
IRR (95%CI) | P-value | IRR (95%CI) | P-value | ||
Measles | 1234 | 0.82 (0.68–0.99) | 0.049 | 0.77 (0.41–1.45) | 0.435 |
Tuberculosis | 876,576 | 0.94 (0.86–1.04) | 0.258 | 1.25 (0.8–1.94) | 0.347 |
Pertussis | 4994 | 3.16 (2.04–4.89) | < 0.001 | 1.54 (0.12–20.07) | 0.748 |
Scarlet fever | 17,206 | 2.47 (1.51–4.03) | 0.002 | 5.47 (0.44–68.04) | 0.211 |
Seasonal influenza | 1,226,804 | 3.4 (1.32–8.75) | 0.020 | 1.55 (0.09–27.01) | 0.770 |
Mumps | 130,911 | 0.97 (0.79–1.2) | 0.793 | 0.54 (0.2–1.46) | 0.249 |
Rubella | 2839 | 0.78 (0.56–1.07) | 0.138 | 1.16 (0.1–13.79) | 0.907 |